Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Management And Outcome Of Recurrent Adult Craniopharyngiomas: An Analysis Of 42 Cases With Long-term Follow-up.

M. Turel, Georgios Tsermoulas, L. Gonen, G. Klironomos, J. P. Almeida, G. Zadeh, F. Gentili
Published 2016 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
OBJECTIVE The treatment of recurrent and residual craniopharyngiomas is challenging. In this study the authors describe their experience with these tumors and make recommendations on their management. METHODS The authors performed an observational study of adult patients (≥ 18 years) with recurrent or residual craniopharyngiomas that were managed at their tertiary center. Retrospective data were collected on demographics and clinical, imaging, and treatment characteristics from patients who had a minimum 2-year follow-up. Descriptive statistics were used and the data were analyzed. RESULTS There were 42 patients (27 male, 15 female) with a mean age of 46.3 ± 14.3 years. The average tumor size was 3.1 ± 1.1 cm. The average time to first recurrence was 3.6 ± 5.5 years (range 0.2-27 years). One in 5 patients (8/42) with residual/recurrent tumors did not require any active treatment. Of the 34 patients who underwent repeat treatment, 12 (35.3%) had surgery only (transcranial, endoscopic, or both), 9 (26.5%) underwent surgery followed by adjuvant radiation therapy (RT), and 13 (38.2%) received RT alone. Eighty-six percent (18/21) had a gross-total (n = 4) or near-total (n = 14) resection of the recurrent/residual tumors and had good local control at last follow-up. One of 5 patients (7/34) who underwent repeat treatment had further treatment for a second recurrence. The total duration of follow-up was 8.6 ± 7.1 years. The average Karnofsky Performance Scale score at last follow-up was 80 (range 40-90). There was 1 death. CONCLUSIONS Based on this experience and in the absence of guidelines, the authors recommend an individualized approach for the treatment of symptomatic or growing tumors. This study has shown that 1 in 5 patients does not require repeat treatment of their recurrent/residual disease and can be managed with a "scan and watch" approach. On the other hand, 1 in 5 patients who had repeat treatment for their recurrence in the form of surgery and/or radiation will require further additional treatment. More studies are needed to best characterize these patients and predict the natural history of this disease and response to treatment.
This paper references
10.3171/JNS.2005.103.2.0224
Surgical management of the recurrence and regrowth of craniopharyngiomas.
Y. Minamida (2005)
10.18999/NAGJMS.74.1-2.141
PROGNOSTIC FACTORS FOR TUMOR RECURRENCE AFTER GAMMA KNIFE RADIOSURGERY OF PARTIALLY RESECTED AND RECURRENT CRANIOPHARYNGIOMAS
T. Kobayashi (2012)
10.1227/01.neu.0000303220.55393.73
EXTENDED ENDOSCOPIC TRANSSPHENOIDAL APPROACH FOR EXTRASELLAR CRANIOPHARYNGIOMAS
E. de Divitiis (2007)
10.3171/2009.2.JNS081026
Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas.
L. Cavallo (2009)
10.3171/JNS.1999.90.2.0237
Surgical treatment of craniopharyngiomas: experience with 168 patients.
R. Fahlbusch (1999)
10.1007/s40618-013-0050-9
Management of craniopharyngiomas
N. Karavitaki (2014)
10.3171/2010.11.JNS10670
Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series.
P. Mortini (2011)
10.3171/FOC.1997.3.6.4
The descriptive epidemiology of craniopharyngioma.
G. Bunin (1998)
10.1038/ng.2868
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
P. Brastianos (2014)
10.3171/JNS/2008/108/4/0715
Expanded endonasal approach, a fully endoscopic transnasal approach for the resection of midline suprasellar craniopharyngiomas: a new classification based on the infundibulum.
A. Kassam (2008)
10.1530/EJE-15-0957
ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.
P. Brastianos (2016)
10.3171/2014.8.GKS141411
Gamma Knife surgery for craniopharyngioma: report on a 20-year experience.
C. Lee (2014)
10.1007/s00701-014-2150-5
Extended endoscopic endonasal approach for recurrent or residual adult craniopharyngiomas
Sung Kwon Kim (2014)
10.1007/BF01772817
Management of primary or recurring grossly cystic craniopharyngiomas by means of draining systems
R. Spaziante (2005)
10.1007/978-3-211-72283-1_4
Extended endoscopic endonasal approach to the midline skull base: the evolving role of transsphenoidal surgery.
P. Cappabianca (2008)
10.3171/2014.3.JNS131521
The endoscopic endonasal approach for the management of craniopharyngiomas: a series of 103 patients.
L. Cavallo (2014)
10.1007/s007010050123
Management of Recurrent Craniopharyngioma
M. Caldarelli (1998)
10.1007/s00276-015-1516-6
The posterior pedicled inferior turbinate–nasoseptal flap: a potential combined flap for skull base reconstruction
Pinghua Wu (2015)
10.1227/01.NEU.0000249211.89096.25
EXTENDED ENDOSCOPIC ENDONASAL TRANSSPHENOIDAL APPROACH FOR THE REMOVALOF SUPRASELLAR TUMORS: PART 2
E. de Divitiis (2007)
10.3171/2015.6.PEDS14520
Endoscopic transnasal external fistulation in recurrent cystic subdiaphragmatic craniopharyngioma: a novel technique.
S. P. Solanki (2016)
10.1002/lary.24319
Beyond the nasoseptal flap: Outcomes and pearls with secondary flaps in endoscopic endonasal skull base reconstruction
M. Patel (2014)
10.1016/j.wneu.2012.10.058
Which side tips the scale for recurrent craniopharyngiomas?
Vita Stagno (2013)
Long term results of stereotactic endocavitary beta irradiation of craniopharyngioma cysts.
C. Munari (1989)
10.1007/s11060-012-0806-7
The superiority of conservative resection and adjuvant radiation for craniopharyngiomas
Adam Schoenfeld (2012)
10.1016/j.wneu.2012.07.033
Predictive factors for craniopharyngioma recurrence: a systematic review and illustrative case report of a rapid recurrence.
R. Prieto (2013)
10.3171/2014.10.PEDS14384
Recurrent craniopharyngioma after conformal radiation in children and the burden of treatment.
P. Klimo (2015)
10.3171/2016.1.JNS152238
Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.
S. Dhandapani (2017)
10.1016/J.YOTO.2011.02.003
Minimally Invasive Endoscopic Pericranial Flap: A New Method for Endonasal Skull Base Reconstruction
R. Sindwani (2011)
10.3171/JNS/2008/108/5/1043
The evolution of the endonasal approach for craniopharyngiomas.
P. Gardner (2008)
Recurrent craniopharyngiomas in children and adults: long-term recurrence rate and management
S. Wien (2014)
10.1016/0167-8140(93)90039-B
Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation.
W. Regine (1993)
10.1007/978-3-7091-8975-7_23
Further experiences in the treatment of cystic craniopharyngeomas with yttrium 90 silicate colloid.
J. Julow (1988)
10.1111/j.1365-2265.2005.02231.x
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long‐term follow‐up
N. Karavitaki (2005)



This paper is referenced by
10.1007/s00701-018-3567-z
Radiation therapy rather than prior surgery reduces extent of resection during endonasal endoscopic reoperation for craniopharyngioma
Iyan Younus (2018)
10.1093/neuros/nyx570
Adult Craniopharyngioma: Case Series, Systematic Review, and Meta-Analysis
Charlotte Dandurand (2018)
Radiation-induced intracranial vasculopathy after radiotherapy (laser surgery) for craniopharyngioma: a study case report
Maksim Tishukov (2019)
10.4236/OJMN.2019.91008
Clinical, Pathological and Surgical Risk Factors Associated with Craniopharyngioma Recurrence: A Literature Review
James Lubuulwa (2019)
10.3171/2018.3.FOCUS1861
Craniopharyngioma: a roadmap for scientific translation.
Saksham Gupta (2018)
10.1016/j.amjoto.2017.06.008
Utilization of sinus stents as a novel approach for benign cystic lesions of the sella.
Akina Tamaki (2017)
10.1007/s10143-020-01370-8
Approach selection and outcomes of craniopharyngioma resection: a single-institute study
C. Lei (2020)
10.1002/alr.22326
ICAR: endoscopic skull‐base surgery
E. Wang (2019)
10.1016/j.wneu.2020.05.172
Craniopharyngiomas: Challenges and Controversies.
Mohammed J Asha (2020)
10.1007/978-3-030-41176-3_8
How to Manage Recurrent Craniopharyngiomas
L. Cavallo (2020)
10.1016/j.wneu.2019.02.212
Immune Microenvironment of Primary and Recurrent Craniopharyngiomas: A Study of the Differences and Clinical Significance.
D. Lin (2019)
10.1093/ons/opy356
Expanded Endonasal Endoscopic Surgery in Suprasellar Craniopharyngiomas: A Retrospective Analysis of 43 Surgeries Including Recurrent Cases.
I. Radovanovic (2019)
10.1016/j.wneu.2020.05.174
Current Results of Surgical Treatment of Craniopharyngiomas: The Impact of Endoscopic Endonasal Approaches.
J. Almeida (2020)
10.1007/s11060-019-03209-9
Outcomes after craniotomy for resection of craniopharyngiomas in adults: analysis of the National Surgical Quality Improvement Program (NSQIP)
Andrew K. Rock (2019)
10.1016/j.adro.2020.07.020
Reirradiation for recurrent craniopharyngioma
Sarah J. Foran (2020)
10.1007/s00701-020-04265-1
Surgical management of craniopharyngiomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section
Giulia Cossu (2020)
10.1007/978-3-030-41176-3
Adult Craniopharyngiomas: Differences and Lessons from Paediatrics
Emmanuel Jouanneau (2020)
10.1016/j.wneu.2020.05.171
Surgical Anatomy Applied to the Resection of Craniopharyngiomas: Anatomic Compartments and Surgical Classifications.
J. Almeida (2020)
10.1080/17446651.2020.1770081
Craniopharyngioma treatment: an updated summary of important clinicopathological concepts
R. Prieto (2020)
Semantic Scholar Logo Some data provided by SemanticScholar